AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Kita, T Tanigawara, Y Chikazawa, S Hatanaka, H Sakaeda, T Komada, F Iwakawa, S Okumura, K
Citation: T. Kita et al., N-acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients, BIOL PHAR B, 24(5), 2001, pp. 544-549

Authors: Nakamura, T Kakumoto, M Yamashita, K Takara, K Tanigawara, Y Sakaeda, T Okumura, K
Citation: T. Nakamura et al., Factors influencing the prediction of steady state concentrations of digoxin, BIOL PHAR B, 24(4), 2001, pp. 403-408

Authors: Aoki, S Shimizu, N Shimonishi, M Kitagawa, M Okumura, K Tanigawara, Y
Citation: S. Aoki et al., Influence of sugar chain on fibrin affinity of recombinant t-PA, BIOL PHAR B, 24(3), 2001, pp. 295-298

Authors: Minami, H Ohtsu, T Fujii, H Igarashi, T Itoh, K Uchiyama-Kokubu, N Aizawa, T Watanabe, T Uda, Y Tanigawara, Y Sasaki, Y
Citation: H. Minami et al., Phase I study of intravenous PSC-833 and doxorubicin: Reversal of multidrug resistance, JPN J CANC, 92(2), 2001, pp. 220-230

Authors: Sakai, T Aoyama, N Kita, T Sakaeda, T Nishiguchi, K Nishitora, Y Hohda, T Sirasaka, D Tamura, T Tanigawara, Y Kasuga, M Okumura, K
Citation: T. Sakai et al., CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects, PHARM RES, 18(6), 2001, pp. 721-727

Authors: Kita, T Tanigawara, Y Aoyama, N Hohda, T Saijoh, Y Komada, F Sakaeda, T Okumura, K Sakai, T Kasuga, M
Citation: T. Kita et al., CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability, PHARM RES, 18(5), 2001, pp. 615-621

Authors: Takama, H Tanaka, H Sudo, T Tamura, T Tanigawara, Y
Citation: H. Takama et al., Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study, CANC CHEMOT, 47(5), 2001, pp. 404-410

Authors: Tanigawara, Y Kita, T Hirono, M Sakaeda, T Komada, F Okumura, K
Citation: Y. Tanigawara et al., Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood, THER DRUG M, 23(4), 2001, pp. 341-346

Authors: Aoki, S Shimizu, N Koyama, J Kato, Y Kitagawa, M Okumura, K Tanigawara, Y
Citation: S. Aoki et al., Influence of N-terminal peptide and oligosaccharide on the clearance of t-PA, BIOL PHAR B, 23(4), 2000, pp. 477-481

Authors: Takara, K Tanigawara, Y Komada, F Nishiguchi, K Sakaeda, T Okumura, K
Citation: K. Takara et al., The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein, JPN J CANC, 91(2), 2000, pp. 248-254

Authors: Tanigawara, Y
Citation: Y. Tanigawara, Role of P-glycoprotein in drug disposition, THER DRUG M, 22(1), 2000, pp. 137-140

Authors: Aoyama, N Tanigawara, Y Kita, T Sakai, T Shirakawa, K Shirasaka, D Kodama, F Okumura, K Kasuga, M
Citation: N. Aoyama et al., Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P4502C19 poor metabolizers, J GASTRO, 34, 1999, pp. 80-83

Authors: Komada, F Nishiguchi, K Tanigawara, Y Iwakawa, S Okumura, K
Citation: F. Komada et al., Effects of secretable SOD delivered by genetically modified cells on xanthine/xanthine oxidase and paraquat-induced cytotoxicity in vitro, BIOL PHAR B, 22(8), 1999, pp. 846-853

Authors: Takara, K Tanigawara, Y Komada, F Nishiguchi, K Sakaeda, T Okumura, K
Citation: K. Takara et al., Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs, BIOL PHAR B, 22(12), 1999, pp. 1355-1359

Authors: Shirakawa, K Takara, K Tanigawara, Y Aoyama, N Kasuga, M Komada, F Sakaeda, T Okumura, K
Citation: K. Shirakawa et al., Interaction of docetaxel ("Taxotere") with human P-glycoprotein, JPN J CANC, 90(12), 1999, pp. 1380-1386

Authors: Tagawa, Y Miwa, K Yamashita, K Tsukuda, R Yoshimura, Y Tanayama, S Tanigawara, Y
Citation: Y. Tagawa et al., Possible factor for nonlinear pharmacokinetics of TAK-603, a new antirheumatic agent, in rats, BIOPHARM DR, 20(1), 1999, pp. 11-18

Authors: Tagawa, Y Miwa, K Tsukuda, R Yoshimura, Y Tanayama, S Tanigawara, Y
Citation: Y. Tagawa et al., Effect of its demethylated metabolite on the pharmacokinetics of unchangedTAK-603, a new antirheumatic agent, in rats, DRUG META D, 27(4), 1999, pp. 495-501

Authors: Tanigawara, Y Aoyama, N Kita, T Shirakawa, K Komada, F Kasuga, M Okumura, K
Citation: Y. Tanigawara et al., CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori, CLIN PHARM, 66(5), 1999, pp. 528-534

Authors: Nishiguchi, K Komada, F Tanigawara, Y Sakai, Y Iwakawa, S Okumura, K
Citation: K. Nishiguchi et al., Effects of Cu,Zn-superoxide dismutase delivered by genetically modified skin fibroblasts on cold-induced skin edema in rats, BIOL PHAR B, 21(12), 1998, pp. 1379-1381

Authors: Kusunoki, N Takara, K Tanigawara, Y Yamauchi, A Ueda, K Komada, F Ku, Y Kuroda, Y Saitoh, Y Okumura, K
Citation: N. Kusunoki et al., Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein, JPN J CANC, 89(11), 1998, pp. 1220-1228
Risultati: 1-20 |